Recurrent squamous cell carcinoma of the skin treated with immunotherapy Srinivasa B J, Sridhar P S, Lalkota BP, Tsikai N, Niyati P S, Shah M, Anuradha S, Roopesh R, Ramaswamy V, Naik R, Ajaikumar B S,

CASE REPORT

Ahead of Print

Recurrent squamous cell carcinoma of the skin treated with immunotherapy BJ Srinivasa¹, PS Sridhar², Bhanu Prakash Lalkota¹, Nomsa Tsikai³, PS Niyati¹, Mansi Shah¹, S Anuradha², R Roopesh², Veena Ramaswamy⁴, Radheshyam Naik¹, BS Ajaikumar² ¹ Department of Medical Oncology, HCG-SC, Bengaluru, Karnataka, India ² Department of Radiation Oncology, HCG-SC, Bengaluru, Karnataka, India ³ Department of Clinical Oncology, Harare Oncology Centre, Harare, Zimbabwe ⁴ Department of Histopathology, HCG-SC, Bengaluru, Karnataka, India Correspondence Address: BJ Srinivasa, Department of Medical Oncology, HCG-SC, Bengaluru - 560 027, Karnataka India Source of Support: None, Conflict of Interest: None DOI: 10.4103/jcrt.JCRT_1018_20

Squamous cell carcinoma (SCC) has a good prognosis, while metastatic tumors have aggressive behavior. Immunotherapy has become a standard line of treatment in metastatic cancers; pembrolizumab has shown promising results and improved quality of life in recurrent and metastatic cancers. We report a case of recurrent SCC of the skin with extensive disease and a known case of human immunodeficiency virus. He completed standard lines of treatment and currently on immunotherapy. After 3 cycles of immunotherapy plus chemotherapy, he got a complete metabolic response. Our experience showed palliative benefits and increased quality of life.

  Search Pubmed for

    -  Srinivasa B J
    -  Sridhar P S
    -  Lalkota BP
    -  Tsikai N
    -  Niyati P S
    -  Shah M
    -  Anuradha S
    -  Roopesh R
    -  Ramaswamy V
    -  Naik R
    -  Ajaikumar B S

Citation Manager

Article Access Statistics

Reader Comments

* Requires registration (Free)